Brad Klos is a builder—of companies, of medical breakthroughs, and of the future of healthtech.

As Managing Partner at E-merge Capital Partners and Evolve Medtech, Brad is at the forefront of early-stage medtech innovation, backing and building technologies that redefine how we treat the body’s most complex systems. He’s also leading from the front as CEO of Cross Vascular, RetractOrtho, and Vector Vascular, turning cutting-edge concepts into commercial reality.

With multiple successful exits—including Traverse Vascular (acquired by Teleflex), SinglePass Transseptal (acquired by Circa Scientific), and Boa Medical—Brad has a proven track record of creating value where science meets surgical precision. Across roles at Philips, Acutus Medical, and InnerCool (now part of ZOLL), he’s delivered impact in cardiology, orthopedics, neurovascular care, drug delivery, and beyond.

He’s led global clinical trials, navigated regulatory landscapes, and holds 12 patents with more on the way. Whether he’s in the lab, the boardroom, or the venture studio, Brad is relentlessly focused on what’s next.

Don’t miss this rare opportunity to hear from someone who not only knows where medtech is headed—but is helping to shape the road there.